On Thursday shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) closed at $12.08. Company’s sales growth for last 5 years was 117.70% and EPS growth for next 5 years is recorded as 5.60%. On March 12, Advanced Cell Diagnostics, Inc. (ACD) announced that Merrimack Pharmaceutical Inc. (NASDAQ:MACK) is utilizing their leading technology to choose participants for a new Phase 2 clinical study to test the efficacy of the company’s drug candidate MM-121. ACD’s RNA scope technology will be used to select patients that have heregulin positive, advanced or metastatic non-small cell lung cancer (NSCLC).
Papa Murphy’s Holdings, Inc. (NASDAQ:FRSH) in last trading activity increased 6.19% to close at $16.47. Company weekly performance is 22.18% while its quarterly performance stands at 63.07%. Papa Murphy’s Holdings, Inc. (NASDAQ:FRSH) is -3.12% away from its 52 week high. On March 17, Papa Murphy’s Holdings Inc., (NASDAQ:FRSH) said that it posted a fourth-quarter profit of $2.8 million. That compares with a net loss of $2.9 million in the same October-to-December period a year earlier.
On last trading day Advaxis, Inc. (NASDAQ:ADXS) increased 6.62% to close at $12.40. Its volatility for the week is 9.76% while volatility for the month is 9.13%. ADXS’s EPS growth for past 5 years was -24.50%. Advaxis, Inc. (NASDAQ:ADXS) monthly performance is 44.35%. Advaxis, Inc. (NASDAQ:ADXS) announced that the first patient was dosed in a Phase 1/2 clinical trial evaluating higher doses and repeat cycles of ADXS-HPV (ADXS11-001), an investigational Lm-LLO immunotherapy, for the treatment of patients with recurrent cervical cancer.
On Thursday shares of Zynga Inc (NASDAQ:ZNGA) closed at $2.65. Company’s sales growth for last 5 years was 41.50% and EPS growth for next 5 years is recorded as 30.00%. On March 11, it was reported that, Zynga Inc (NASDAQ:ZNGA) has released a trailer for Dawn of Titans, a strategy game unlike anything we’ve seen from the publisher before. Its $527 million purchase of Natural Motion, the developer behind Clumsy Ninja, may be about to pay off in a big way. It hopes Dawn will appeal to both the casual crowd and the player who sees opening gambits in their sleep.
On last trading day Magnum Hunter Resources Corp. (NYSE:MHR) remains unchanged to close at $2.32. Its volatility for the week is 9.23% while volatility for the month is 7.45%. MHR’s sales growth for past 5 years was 124.90% and its EPS growth for past 5 years was -26.00%. Magnum Hunter Resources Corp. (NYSE:MHR) monthly performance is -9.73%. Zacks lowered shares of Magnum Hunter Resources Corp (NYSE:MHR) from a neutral rating to an underperform rating in a research report released on Thursday morning. Zacks currently has $2.20 price objective on the stock.